Fig. 4
From: A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer
Kaplan-Meier analysis for RFS using RRS in the subgroups stratified by ER status and endocrine therapy. a Kaplan-Meier curves for early-stage BIDC patients with ER-positive status. b Kaplan-Meier curves for early-stage BIDC patients with ER-negative status. c Kaplan-Meier curves for ER-positive patients with high risk scores stratified by endocrinotherapy. d Kaplan-Meier curves for ER-positive patients with low risk scores stratified by endocrinotherapy